Spebrutinib (CC-292, AVL-292) Motor

Spebrutinib (CC-292, AVL-292) MotorSpebrutinib (CC 292, AVL 292) is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0. 5 nM, displaying at least 1400 fold selectivity over the other kinases assayed. Phase 1.

feature Dual Core 2 x 1 GHz processor which delivers noticeable performance improvements including faster operation and shorter stabilization time retaining high repeatability values

2µm filter

9 nM for Pim1

Tyrosine Kinase Inhibitor library is ideal database for high-throughput screening (HTS) and cell based high-content screening (HCS)

7 nAChR with EC50 of 216 nM

Valsartan is a selective angiotensin II receptor antagonist

data backup

copper-binding

Pimecrolimus is an immunophilin ligand

antivenins

including sclerotinia rot of canola

Corning These heavy duty 150mL PYREX® round bottles can be used for storage as well as mixing and sampling